160 related articles for article (PubMed ID: 23824834)
1. Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.
Bodelon C; Madeleine MM; Johnson LG; Du Q; Galloway DA; Malkki M; Petersdorf EW; Schwartz SM
Int J Cancer; 2014 Jan; 134(2):437-44. PubMed ID: 23824834
[TBL] [Abstract][Full Text] [Related]
2. Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.
Hussain SK; Madeleine MM; Johnson LG; Du Q; Galloway DA; Daling JR; Malkki M; Petersdorf EW; Schwartz SM
Int J Cancer; 2013 Jul; 133(1):201-13. PubMed ID: 23280621
[TBL] [Abstract][Full Text] [Related]
3. A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.
Hardikar S; Johnson LG; Malkki M; Petersdorf EW; Galloway DA; Schwartz SM; Madeleine MM
Gynecol Oncol; 2015 Oct; 139(1):90-6. PubMed ID: 26241630
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.
Bodelon C; Madeleine MM; Johnson LG; Du Q; Malkki M; Petersdorf EW; Schwartz SM
Gynecol Oncol; 2012 Mar; 124(3):525-8. PubMed ID: 22134374
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
7. Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.
Hussain SK; Madeleine MM; Johnson LG; Du Q; Malkki M; Wilkerson HW; Farin FM; Carter JJ; Galloway DA; Daling JR; Petersdorf EW; Schwartz SM
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1790-9. PubMed ID: 18628433
[TBL] [Abstract][Full Text] [Related]
8. Association of DNA Repair Genes XRCC1 and APE-1 with the Risk of Cervical Cancer in North Indian population.
Charles MR; Raza ST; Sharma R; Pratap P; Eba A; Singh M
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2061-2065. PubMed ID: 32711433
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women.
Araújo AP; Catarino R; Ribeiro R; Pereira D; Pinto D; Medeiros R
Am J Clin Oncol; 2012 Jun; 35(3):247-50. PubMed ID: 21358296
[TBL] [Abstract][Full Text] [Related]
10. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Toll-like receptors in cervical cancer susceptibility among Tunisian women.
Zidi S; Verdi H; Yilmaz-Yalcin Y; Yazici AC; Gazouani E; Mezlini A; Atac FB; Yacoubi-Loueslati B
Bull Cancer; 2014 Oct; 101(10):E31-5. PubMed ID: 25373689
[TBL] [Abstract][Full Text] [Related]
12. Cofactors with human papillomavirus in a population-based study of vulvar cancer.
Madeleine MM; Daling JR; Carter JJ; Wipf GC; Schwartz SM; McKnight B; Kurman RJ; Beckmann AM; Hagensee ME; Galloway DA
J Natl Cancer Inst; 1997 Oct; 89(20):1516-23. PubMed ID: 9337348
[TBL] [Abstract][Full Text] [Related]
13. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
Chen D; Gyllensten U
Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.
Maley SN; Schwartz SM; Johnson LG; Malkki M; Du Q; Daling JR; Li SS; Zhao LP; Petersdorf EW; Madeleine MM
Int J Immunogenet; 2009 Dec; 36(6):367-75. PubMed ID: 19788587
[TBL] [Abstract][Full Text] [Related]
15. TNF-α -308 G/A as a risk marker of cervical cancer progression in the Polish population.
Roszak A; Misztal M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2015 Feb; 19(1):53-7. PubMed ID: 25614219
[TBL] [Abstract][Full Text] [Related]
16. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
17. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
Huang FY; Kwok YK; Lau ET; Tang MH; Ng TY; Ngan HY
Cancer Genet Cytogenet; 2005 Feb; 157(1):42-8. PubMed ID: 15676146
[TBL] [Abstract][Full Text] [Related]
18. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility.
Pandey S; Mittal B; Srivastava M; Singh S; Srivastava K; Lal P; Mittal RD
Mol Biol Rep; 2011 Oct; 38(7):4715-21. PubMed ID: 21132533
[TBL] [Abstract][Full Text] [Related]
20. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
